Page 7 - Bharat Biotech

Indian Immunologicals may start supplying 2 mn Covaxin doses by Sep: Govt

NITI Aayog member (Health) Dr V K Paul said there were some initial hiccups related to standardisation quality assurances of batches of vaccines at Bangalore plant, which delayed production

Bharat Biotech's Covaxin effective against Delta plus variant, says study

The study released on Monday showed that Covaxin provides 65.2 per cent protection against the Delta variant which was first detected in India

Bharat Biotech's Covaxin effective against Delta Plus variant: ICMR study

Bharat Biotech's Covid-19 vaccine Covaxin (BBV152) is effective against Delta Plus (AY.1) variant of the coronavirus, according to a study by the Indian Council of Medical and Research

Bharat Biotech's Rotavac 5D receives WHO Prequalification

Bharat Biotech on Monday announced that the World Health Organisation has awarded prequalification to its rotavirus vaccine,Rotavac 5D to prevent rotavirus diarrhea, the company said.

India may soon have Covid-19 vaccines for children. All you need to know

Zydus Cadila DNA-plasmid vaccine is the prime contender. It has held trials on children aged 12 years and above

Expert panel recommends trials on mixing Covaxin and Covishield

As per sources, the application of the interchangeability study protocol of Covishield and Covaxin was moved by Christian Medical College (CMC) in Vellore.

Covid-19 vaccine for children likely in August: Health minister Mandaviya

Zydus Cadila has done trials on 12-plus; Bharat Biotech conducting trials on two-plus

India to miss July-end Covid vaccination target as Bharat Biotech lags

The government had been counting on deliveries of 60 million to 70 million Covaxin doses monthly from July or August.

Brazil suspends clinical trials of Covaxin after termination of agreement

Brazil has suspended the clinical studies of Bharat Biotech's Covaxin following termination of the company's agreement with its partner there, the South American Country's health regulator said

Bharat Biotech axes Covid vaccine deal with Brazil's Precisa: Statement

Bharat's statement said it will continue to work with Brazilian health care regulator Anvisa to obtain all required approvals for the use of Covaxin in the country

Bharat Biotech's Bengaluru unit has overcome glitches, says V K Paul

Bharat Biotech is hoping to manufacture 1 billion doses per annum by the end of this year.

Process to receive WHO pre-qualification for Covaxin on, says govt

Covishield manufactured by the Serum Institute of India (SII) has received the WHO pre-qualification, while the process of pre-qualification for Bharat Biotech's Covaxin is going on

Bharat Biotech had agreed to offer vaccine at reasonable rates to Govt: MoH

ICMR has spent Rs 35 cr on Covaxin clinical trials

WHO assessing Covaxin data for EUL; decision date 'to be confirmed'

WHO, which is currently reviewing Bharat Biotech's application for an Emergency Use Listing of its Covid-19 vaccine Covaxin, has said it is assessing the data of the jab

New price good, but Rs 250 a dose better: Covid-19 vaccine makers

Centre has ordered 660 mn doses, expected to be supplied between Aug & Dec

Small contract manufacturers wait to take a shot at Covid vaccines

A host of lesser-known vaccine makers are eyeing contract manufacturing opportunities for global and domestic majors

Related party risks

Bharat Bio-Brazil investigation reveals dangers of offshore agencies

Best of BS Opinion: Related party risks, a new green wave of growth & more

Here are the best of Business Standard's opinion pieces for Wednesday

Bharat Biotech-Brazil row: Covaxin nod under controlled conditions

The agency said the suspension - which put the EUA application on ice - was due to missing data from the vaccine's clinical trials

A bottleneck in the vaccine chain

Prosenjit Datta points to a possible crisis as the government moves to improve supplies of Covid vaccines: inadequate testing facilities to handle those volumes